⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2113347 | 0.82 | — | — | |
| SCHEMBL16281734 | 0.75 | — | — | |
| SCHEMBL2111822 | 0.75 | — | — | |
| SCHEMBL15088185 | 0.74 | — | — | |
| SCHEMBL11011215 | 0.73 | — | — | |
| SCHEMBL3393860 | 0.67 | ADORA2A (0.38) | — | |
| SCHEMBL16461044 | 0.66 | LMNA (0.40) | — | |
| SCHEMBL3803757 | 0.66 | NPSR1 (0.42) | — | |
| SCHEMBL13823338 | 0.65 | NPSR1 (0.35) | — | |
| SCHEMBL23053284 | 0.64 | TDP1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2402349-B1 | TRICYCLIC PYRAZOLOPYRIMIDINE DERIVATIVES | DAIICHI SANKYO CO LTD (JP) | 2016-04-06 | — | — | EP | disclosed |
| US-20140371249-A1 | CRYSTAL OF A FREE TRICYCLIC PYRAZOLOPYRIMIDINE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-12-18 | — | — | US | disclosed |
| US-20140371249-A1 | CRYSTAL OF A FREE TRICYCLIC PYRAZOLOPYRIMIDINE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-12-18 | — | — | US | disclosed |
| US-20140371249-A1 | CRYSTAL OF A FREE TRICYCLIC PYRAZOLOPYRIMIDINE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-12-18 | — | — | US | disclosed |
| EP-2810945-A1 | Dihydrochloride salt of a tricyclic pyrazolopyrimidine derivative | Daiichi Sankyo Company, Limited (JP) | 2014-12-10 | — | — | EP | disclosed |
| US-8846703-B2 | Crystal of a free tricyclic pyrazolopyrimidine derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-09-30 | — | — | US | disclosed |
| US-8846703-B2 | Crystal of a free tricyclic pyrazolopyrimidine derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-09-30 | — | — | US | disclosed |
| US-8846703-B2 | Crystal of a free tricyclic pyrazolopyrimidine derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-09-30 | — | — | US | disclosed |
| US-8815880-B2 | Crystal of tricyclic pyrazolopyrimidine derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-08-26 | — | — | US | disclosed |
| US-8815880-B2 | Crystal of tricyclic pyrazolopyrimidine derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-08-26 | — | — | US | disclosed |
| EP-2065388-B1 | PYRAZOLOPYRIMIDINE DERIVATIVE | DAIICHI SANKYO CO LTD (JP) | 2011-09-07 | — | — | EP | disclosed |
| US-20110071170-A1 | TRICYCLIC PYRAZOLOPYRIMIDINE DERIVATIVES | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2011-03-24 | — | — | US | disclosed |
| US-20110071170-A1 | TRICYCLIC PYRAZOLOPYRIMIDINE DERIVATIVES | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2011-03-24 | — | — | US | disclosed |
| US-20110071170-A1 | TRICYCLIC PYRAZOLOPYRIMIDINE DERIVATIVES | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2011-03-24 | — | — | US | disclosed |
| WO-2010098344-A1 | TRICYCLIC PYRAZOLOPYRIMIDINE DERIVATIVE | 第一三共株式会社 (JP) | 2010-09-02 | — | — | WO | disclosed |
| US-20100113410-A1 | PYRAZOLOPYRIMIDINE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2010-05-06 | — | — | US | disclosed |
| US-20100113410-A1 | PYRAZOLOPYRIMIDINE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2010-05-06 | — | — | US | disclosed |
| US-20100113410-A1 | PYRAZOLOPYRIMIDINE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2010-05-06 | — | — | US | disclosed |
| EP-2065388-A1 | PYRAZOLOPYRIMIDINE DERIVATIVE | Daiichi Sankyo Company, Limited (JP) | 2009-06-03 | — | — | EP | disclosed |
| EP-2065388-A1 | PYRAZOLOPYRIMIDINE DERIVATIVE | Daiichi Sankyo Company, Limited (JP) | 2009-06-03 | — | — | EP | disclosed |